Eric joined Genetesis in September 2018. Previously, he was a Controller with US Oncology where, he led the transition of accounting and finance functions from Oncology Hematology Care (OHC) to US Oncology. While at US Oncology, he was able to reduce the finance department headcount by 50% by taking advantage of shared savings opportunities and help the organization save $4 million annually in operating costs. At OHC, he was responsible for all the finance and accounting functions for a $250 million annual revenue physician practice. Prior to his time with OHC, he worked in public accounting performing financial statement audits, internal audits and Sarbanes-Oxley consulting services across multiple different industries.